TB REACH’s Wave 9 Funds Over USD 6 Million

To strengthen the fight against drug-resistant TB

22 July 2021, Geneva, Switzerland. The Stop TB Partnership’s TB REACH initiative is excited to announce the approval of 11 new projects selected for funding to address inequities in drug-resistant tuberculosis (DR-TB) in partnership with the United States Agency for International Development (USAID) Global Accelerator to End TB, which helps countries reach targets and commitments set at the UN High-Level Meeting on TB.
With generous funding support from USAID and Global Affairs Canada, TB REACH is awarding USD 6.14 million to help reduce initial or pre-treatment loss to follow up for people with DR-TB, use innovative approaches to expand access to new, all-oral treatment regimens, and improve treatment adherence and outcomes for people with DR-TB.
The Wave 9 call for proposals was launched in January 2021 and received almost 300 applications from 24 countries with a total funding request of USD 145 million. All completed submissions were reviewed by an independent Proposal Review Committee (PRC), who selected 48 applicants to be invited to submit a more in-depth stage 2 proposal. These applications underwent another round of diligent review by the PRC.  After an 8-day review meeting, the PRC selected the top applications until the funding ceiling was reached; overall, 11 proposals from 8 countries were recommended for funding.
Wave 9 grantees will help get children and adults onto newer, shorter all-oral regimens; introduce new rapid molecular tests to detect second-line drug resistance; and bring more services for DR-TB to internally displaced people, rural communities, and people with low access to care.

TB REACH would like to thank all applicants for their continued support and interest in the initiative.